Blood Glucose Monitoring Systems Market size, analysis, and forecast report by 2026 Overview: Blood glucose monitoring is an integral part of the standard diabetes care, and it is very helpful in controlling
BriefingWire.com, 5/05/2021 - Overview: Blood glucose monitoring is an integral part of the standard diabetes care, and it is very helpful in controlling the glucose levels in individuals with diabetes and impaired glucose tolerance. The incidence of diabetes is increasing globally, and around 90% of the patients have type 2 diabetes mellitus with approximately one-fifth of the people undergoing insulin treatment. Self-monitoring blood glucose (SMBG) systems and continuous glucose monitoring (CGM) systems are two major types of blood glucose monitoring systems.
According to the latest market report published by Future Market Insights, titled ‘Global Amniotic Membrane Market: Global Industry Analysis 2013 – 2017 and Opportunity Assessment 2018 – 2028′, the global amniotic membrane market is expected to expand at a CAGR of 9.3% over the forecast period 2018-2028.FMI estimate.
Share:
Newark, NJ, Feb. 11, 2021 (GLOBE NEWSWIRE) As per the report published by Fior Markets, the
global haematological cancer therapeutics market is expected to grow from USD 37.88 billion in 2020 and to reach USD 82.40 billion by 2028, growing at a CAGR of 10.2% during the forecast period 2021-2028.
The global hematological cancers therapeutics market is witnessing significant growth in recent years. This growth is attributed to the increased government spending and infrastructure development rate across the globe, increasing blood cancer incidences, and increasing investment in research and development. Other factors propelling the market growth include inventions of novel drugs and growing investment in research and development.